Accuray is expected to report a fiscal first-quarter revenue of $95.80 million and an EPS loss of $0.07, as the stock currently trades at roughly $0.15 against a significantly lowered $0.35 analyst median price target. Investors are primarily focused on the recovery of gross orders and the company's ability to convert its $312.5 million backlog into realized revenue following severe geopolitical delays in the Middle East and China. Recent performance has been pressured by a withdrawal of full-year 2026 guidance and a nearly 90% year-over-year decline in share price. Management's progress on its $25 million annualized transformation plan and the impact of the new Chief Commercial Officer on global execution will be central to the quarterly narrative.